“…Studies against NNV were focused on the development of vaccine, immuno-stimulants and other means [22,23]. However, ever since the first report on the antiviral activities of cecropin B against infectious hematopoietic necrosis virus (IHNV), viral hemorrhagic septicemia virus (VHSV), snakehead rhabdovirus (SHRV), and infectious pancreatic necrosis virus (IPNV) [24], more emerging studies are highlighting the benefits of AMP application on disease control, for example, not eliciting resistance in bacteria, compared with conventional antibiotic therapeutics. In this study, we examined the antiviral activities of three AMPs against NNV in fish cells, and elucidated their anti-NNV mechanisms in vitro.…”